Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4764142
Max Phase: Preclinical
Molecular Formula: C27H24N2O2
Molecular Weight: 408.50
Molecule Type: Unknown
Associated Items:
ID: ALA4764142
Max Phase: Preclinical
Molecular Formula: C27H24N2O2
Molecular Weight: 408.50
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COc1c(OC)c2c3c(nccc3c1-c1cccc(C)c1)C(c1cccc(C)c1)=CN2
Standard InChI: InChI=1S/C27H24N2O2/c1-16-7-5-9-18(13-16)21-15-29-25-23-20(11-12-28-24(21)23)22(26(30-3)27(25)31-4)19-10-6-8-17(2)14-19/h5-15,29H,1-4H3
Standard InChI Key: USNPPRRTTSTRDX-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 408.50 | Molecular Weight (Monoisotopic): 408.1838 | AlogP: 6.35 | #Rotatable Bonds: 4 |
Polar Surface Area: 43.38 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 6.44 | CX LogP: 5.53 | CX LogD: 5.49 |
Aromatic Rings: 4 | Heavy Atoms: 31 | QED Weighted: 0.43 | Np Likeness Score: 0.28 |
1. Yang F,Gao Y,Chang YT,Zou Y,Houk KN,Lu JR,He J,Tang WZ,Liao HZ,Han H,Lin HW. (2020) Aromatic Ring Substituted Aaptamine Analogues as Potential Cytotoxic Agents against Extranodal Natural Killer/T-Cell Lymphoma., 83 (12): [PMID:33170001] [10.1021/acs.jnatprod.0c00769] |
Source(1):